2016 American Transplant Congress
The Impact of Ritonavir-Boosted Protease Inhibitors and Non-Depleting Antibody Induction on Outcomes in HIV-Infected Kidney Transplant Recipients.
Mount Sinai Hospital, New York.
Background: One-year rejection rates in HIV-infected kidney transplant recipients range from 15-40%, compared to overall rejection rates of 10% in HIV-negative patients. Protocols for immunosuppression…2015 American Transplant Congress
Disparities in Death and Delisting on the Waitlist for Renal Transplant in the United States
Medicine, University of Virginia, Charlottesville, VA.
Waiting time to kidney transplant varies dramatically among organ procurement organizations (OPOs) in the US. We sought to evaluate the association between death and delisting…2015 American Transplant Congress
Initial Experience With a Tailor-Made Simulation and Navigation Program Using a 3D Printer Model of Kidney Transplantation Surgery
Introduction: Three-dimensional (3D) printing systems allow for the creation of surgical models mimicking real tissue. We developed a kidney graft and pelvic cavity replica as…2015 American Transplant Congress
Toxoplasmosis Post-Kidney Or Liver Transplantation: A Serie of Cases
Toxoplasmosis is a rare complication post-SOT, occurring mostly in D+/R- mismatch. However, in highly endemic areas, the disease occurs predominantly in R+ under post-tx immunosuppressive…2015 American Transplant Congress
Early Hospital Readmissions After Kidney Transplantation
Transplantation, Montefiore Medical Center, Bronx, NY.
Early rehospitalization after kidney transplantation is common and is considered a quality metric. Few studies have examined preventability or specific transplant/discharge factors associated with early…2015 American Transplant Congress
Non-Chimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers
Background. We previously described 3-year results of a non-chimeric tolerance protocol in HLA-identical living donor renal transplant (RT) recipients and now report on longer term,…2015 American Transplant Congress
Protecting Older Patients from Dialysis: The Survival Benefit of Preemptive Transplant With High KDPI Allografts
BACKGROUND: Mortality on dialysis remain markedly elevated in patients over 60 years old. Preemptive kidney transplantation (PreKT) represents a means of avoiding the risks of…2015 American Transplant Congress
Incidence of CMV Viremia in Obese and Morbidly Obese Kidney Transplants Under a Low Dose Valganciclovir Prophylaxis Protocol
1Pharmacy Practice, Univ of IL-Chicago, Chicago, IL; 2Surgery, Univ of IL-Chicago, Chicago, IL.
Background: The rate of Cytomegalovirus infections in kidney transplant recipients drastically diminished with the advent of oral ganciclovir and subsequently valganciclovir. However it continues to…2015 American Transplant Congress
Effect of Everolimus on Left Ventricular Hypertrophy in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study
Background: Left ventricular hypertrophy (LVH) is common in kidney transplant recipients (KTxR) and has shown to be a risk factor for death and heart failure…2015 American Transplant Congress
Everolimus Conversion to Treat BK Virus Infection in Kidney Transplant Recipients
IntroductionmTORi's reduce BKV large T antigen expression in vitro and are associated with lower rates of BKV infection in clinical studies.MethodsPilot single center, randomized, open-label…
- « Previous Page
- 1
- …
- 467
- 468
- 469
- 470
- 471
- …
- 531
- Next Page »